TERN
TERN
NASDAQ · Pharmaceuticals

Terns Pharmaceuticals Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$52.86
+2.86 (+5.72%)
As of Mar 25, 9:56 PM ET ·
TERN News1 articles
Merck Acquires Terns Pharma in $6.7B Deal to Fortify Cancer Portfolio
Merck will purchase Terns Pharmaceuticals for $53 per share in cash, a transaction valued at approximately $6.7 billion. The acquisition provides Merck with an experimental leukemia therapy as it prepares for the loss of exclusivity for its blockbuster drug Keytruda.
Markets